Literature DB >> 31326273

CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA4 Cleavage with ApA>p Formation Terminating RNase Activity.

Ning Jia1, Roger Jones2, Guangli Yang3, Ouathek Ouerfelli3, Dinshaw J Patel4.   

Abstract

Type III-A CRISPR-Cas surveillance complexes containing multi-subunit Csm effector, guide, and target RNAs exhibit multiple activities, including formation of cyclic-oligoadenylates (cAn) from ATP and subsequent cAn-mediated cleavage of single-strand RNA (ssRNA) by the trans-acting Csm6 RNase. Our structure-function studies have focused on Thermococcus onnurineus Csm6 to deduce mechanistic insights into how cA4 binding to the Csm6 CARF domain triggers the RNase activity of the Csm6 HEPN domain and what factors contribute to regulation of RNA cleavage activity. We demonstrate that the Csm6 CARF domain is a ring nuclease, whereby bound cA4 is stepwise cleaved initially to ApApApA>p and subsequently to ApA>p in its CARF domain-binding pocket, with such cleavage bursts using a timer mechanism to regulate the RNase activity of the Csm6 HEPN domain. In addition, we establish T. onnurineus Csm6 as an adenosine-specific RNase and identify a histidine in the cA4 CARF-binding pocket involved in autoinhibitory regulation of RNase activity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A CARF histidine contributes to autoinhibition; Csm6 CARF is a ring nuclease; Csm6 is an adenosine-specific RNase; Sequential cleavage bursts regulate RNase activity; Type III-A CRISPR-Cas Csm

Mesh:

Substances:

Year:  2019        PMID: 31326273      PMCID: PMC6731128          DOI: 10.1016/j.molcel.2019.06.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

1.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

Review 2.  CRISPR-Cas immunity in prokaryotes.

Authors:  Luciano A Marraffini
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

3.  Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.

Authors:  Ning Jia; Charlie Y Mo; Chongyuan Wang; Edward T Eng; Luciano A Marraffini; Dinshaw J Patel
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

4.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

5.  Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity.

Authors:  Wenyan Jiang; Poulami Samai; Luciano A Marraffini
Journal:  Cell       Date:  2016-02-04       Impact factor: 41.582

Review 6.  Conformational regulation of CRISPR-associated nucleases.

Authors:  Ryan N Jackson; Paul Bg van Erp; Samuel H Sternberg; Blake Wiedenheft
Journal:  Curr Opin Microbiol       Date:  2017-06-21       Impact factor: 7.934

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

9.  RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex.

Authors:  Michael A Estrella; Fang-Ting Kuo; Scott Bailey
Journal:  Genes Dev       Date:  2016-02-04       Impact factor: 11.361

10.  Control of cyclic oligoadenylate synthesis in a type III CRISPR system.

Authors:  Christophe Rouillon; Januka S Athukoralage; Shirley Graham; Sabine Grüschow; Malcolm F White
Journal:  Elife       Date:  2018-07-02       Impact factor: 8.140

View more
  32 in total

1.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

2.  Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.

Authors:  Beibei Wang; Tianlong Zhang; Jun Yin; You Yu; Wenhao Xu; Jianping Ding; Dinshaw J Patel; Hui Yang
Journal:  Mol Cell       Date:  2021-01-19       Impact factor: 17.970

Review 3.  Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins.

Authors:  Ning Jia; Dinshaw J Patel
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-04       Impact factor: 94.444

Review 4.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

5.  Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR-Cas that degrades the second messenger cA4.

Authors:  Sharidan Brown; Colin C Gauvin; Alexander A Charbonneau; Nathaniel Burman; C Martin Lawrence
Journal:  J Biol Chem       Date:  2020-08-21       Impact factor: 5.157

6.  Evolutionary and functional classification of the CARF domain superfamily, key sensors in prokaryotic antivirus defense.

Authors:  Kira S Makarova; Albertas Timinskas; Yuri I Wolf; Ayal B Gussow; Virginijus Siksnys; Česlovas Venclovas; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2020-09-18       Impact factor: 16.971

7.  Cyclic di-AMP, a second messenger of primary importance: tertiary structures and binding mechanisms.

Authors:  Jin He; Wen Yin; Michael Y Galperin; Shan-Ho Chou
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

Review 8.  HEPN RNases - an emerging class of functionally distinct RNA processing and degradation enzymes.

Authors:  Monica C Pillon; Jacob Gordon; Meredith N Frazier; Robin E Stanley
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-12-22       Impact factor: 8.250

Review 9.  Controlling and enhancing CRISPR systems.

Authors:  Haridha Shivram; Brady F Cress; Gavin J Knott; Jennifer A Doudna
Journal:  Nat Chem Biol       Date:  2020-12-16       Impact factor: 15.040

10.  Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR-Cas immunity.

Authors:  Kawanda Foster; Sabine Grüschow; Scott Bailey; Malcolm F White; Michael P Terns
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.